Low Virus Nosode

FDA Drug Profile — Low Virus Nosode 4023

Low Virus Nosode is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including Low Virus Nosode 4023. Available dosage form: liquid.

Drug Details

Generic Name
Low Virus Nosode
Brand Names
Low Virus Nosode 4023
Application Number
Sponsor
Professional Complementary Health Formulas
NDC Codes
1
Dosage Forms
LIQUID
Routes
ORAL
Active Ingredients
COXSACKIEVIRUS A21, HUMAN HERPESVIRUS 5, HUMAN HERPESVIRUS 4, HAEMOPHILUS INFLUENZAE, DALEA FOLIOLOSA WHOLE, DRABA VERNA WHOLE, JUSTICIA SPICIGERA LEAF, VACCINIA VIRUS STRAIN NEW YORK CITY BOARD OF HEALTH LIVE ANTIGEN, HUMAN VARICELLA-ZOSTER IMMUNE GLOBULIN, BACILLUS CALMETTE-GUERIN LIVE ANTIGEN, UNSPECIFIED SUBSTRAIN, POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED)

Indications and Usage

INDICATIONS Temporarily relieves fatigue, sore throat, minor aches and pains in the muscles or joints, occasional headache, chills, sweats, cough, nausea or vomiting, or abdominal discomfort.*

Warnings

WARNINGS Persistent symptoms may be a sign of a serious condition. If symptoms persist or are accompanied by a fever, rash, or persistent headache, consult a doctor. Keep out of the reach of children. In case of overdose, get medical help or contact a poison control center right away. If pregnant or breastfeeding, ask a healthcare professional before use. Keep out of the reach of children. If pregnant or breastfeeding, ask a healthcare professional before use.